These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6084216)

  • 1. Xenon arc photocoagulation of proliferative diabetic retinopathy. A review of 2688 consecutive eyes in the format of the Diabetic Retinopathy Study.
    Okun E; Johnston GP; Boniuk I; Arribas NP; Escoffery RF; Grand MG
    Ophthalmology; 1984 Dec; 91(12):1458-63. PubMed ID: 6084216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenon arc photocoagulation of proliferative diabetic retinopathy (a review of 2688 consecutive eyes in the format of the diabetic retinopathy study--DRS).
    Okun E; Johnston GP; Boniuk I; Arribas N; Escoffery RF; Grand MG
    Trans Am Ophthalmol Soc; 1983; 81():229-45. PubMed ID: 6676970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photocoagulation for optic disc new vessels in diabetes mellitus.
    Asher R; Hunt S; Hamilton AM; Townsend C; Blach RK; Khoury D; Kohner EM; Morris DV
    Int Ophthalmol; 1981 Mar; 3(2):79-85. PubMed ID: 6164659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy.
    Plumb AP; Swan AV; Chignell AH; Shilling JS
    Br J Ophthalmol; 1982 Apr; 66(4):213-8. PubMed ID: 6175340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group.
    Ophthalmology; 1981 Jul; 88(7):583-600. PubMed ID: 7196564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinopathy risk factor regression after laser panretinal photocoagulation for proliferative diabetic retinopathy.
    Doft BH; Blankenship G
    Ophthalmology; 1984 Dec; 91(12):1453-7. PubMed ID: 6084215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 1. Effect on disc vessels, visual fields, and visual acuity.
    Hamilton AM; Townsend C; Khoury D; Gould E; Blach RK
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):87-92. PubMed ID: 6192562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 2. Effect on colour vision.
    Birch J; Hamilton AM
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):93-9. PubMed ID: 6192563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative management of diabetic retinopathy using photocoagulation with the Argon laser and Xenon high-pressure lamp. I. Theoretical principles of phototherapy, side-effects and apparatus design].
    Fankhauser F; Lotmar W; Roulier A
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1972; 183(4):334-47. PubMed ID: 4537009
    [No Abstract]   [Full Text] [Related]  

  • 10. Arrest and regression of retinal neovascularization.
    Scott JD
    Trans Ophthalmol Soc U K (1962); 1981; 101 (Pt 2)():209-11. PubMed ID: 6192564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative electroretinograms in argon laser and xenon arc panretinal photocoagulation.
    Liang JC; Fishman GA; Huamonte FU; Anderson RJ
    Br J Ophthalmol; 1983 Aug; 67(8):520-5. PubMed ID: 6683566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of proliferative diabetic retinopathy. Long-term results of argon laser photocoagulation.
    Little HL
    Ophthalmology; 1985 Feb; 92(2):279-83. PubMed ID: 2580259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argon laser v. xenon arc photocoagulation in proliferative diabetic retinopathy.
    Crick MD; Chignell AH; Shilling JS
    Trans Ophthalmol Soc U K (1962); 1978 Apr; 98(1):170-1. PubMed ID: 285502
    [No Abstract]   [Full Text] [Related]  

  • 14. Laser treatment in diabetic retinopathy.
    O'Donoghue HN
    Trans Ophthalmol Soc U K (1962); 1982; 102 (Pt 4)():468-70. PubMed ID: 6194597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitrectomy and subsequent photocoagulation in proliferative diabetic retinopathy with vitreous hemorrhage].
    Gerke E; Alvira G
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):5-8. PubMed ID: 2421045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus.
    Grunwald JE; Riva CE; Brucker AJ; Sinclair SH; Petrig BL
    Ophthalmology; 1984 Dec; 91(12):1447-52. PubMed ID: 6084214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argon Laser Photocoagulation of proliferative diabetic retinopathy.
    Little HL
    Int Ophthalmol Clin; 1976; 16(4):79-103. PubMed ID: 1033166
    [No Abstract]   [Full Text] [Related]  

  • 18. Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic retinopathy study report no. 5.
    Dev Ophthalmol; 1981; 2():248-61. PubMed ID: 7262408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifteen-year argon laser and xenon photocoagulation results of Bascom Palmer Eye Institute's patients participating in the diabetic retinopathy study.
    Blankenship GW
    Ophthalmology; 1991 Feb; 98(2):125-8. PubMed ID: 2008268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic correlation of xenon arc and argon laser photocoagulation. Procedure in human diabetic eyes.
    Wallow IH; Davis MD
    Arch Ophthalmol; 1979 Dec; 97(12):2308-15. PubMed ID: 574760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.